The birth of Mayo Clinic Laboratories: From tiny operation to international mainstay - Insights
In 1971, the Regional Laboratory, later to become Mayo Clinic Laboratories, was founded. For the first time in Mayo Clinic’s history, the institution would support the community practice of pathology for outside patients in the region and...
MCL Allergen Test Request MC076708
MCL Allergen Test Request Complete print Reset Form Allergen Test Request Client Information required Client Patient Information required Patient ID Medical Record
Platelet Transmission Electron Microscopy and Flow Cytometry - Insights
In this "Hot Topic," Dong Chen, M.D., Ph.D., describes how flow cytometry, electron micrographic study, and molecular testing are used to diagnose platelet function disorders.
Pushing the envelope on personalized medicine - Insights
Recognizing the powerful role genes can play in diagnosing illness and guiding treatment, the Division of Laboratory Genetics and Genomics at Mayo Clinic spearheaded a testing expansion, implementing and upgrading more than 60 advanced...
Ceramide testing provides algorithmic score for heart attack risk - Insights
Mayo Clinic Laboratories offers a ceremide test to advise patients and their clinicians of the potential risk of heart attack. Using liquid chromatography-mass spectrometry technology, the test renders an algorithmic score after sorting...
Learn how Mayo Clinic Laboratories’ outreach solutions can enhance and promote the clinical, business, and operational relevance of the hospital laboratory.
COVID-19 weekly news: April 11-17 2022 - Insights
Topics include: Why women's risk of heart disease increased during the pandemic and information about the most commonly asked questions for when to get your second COVID-19 booster.
Learn more about how carrier screening at Mayo Clinic Laboratories can provide prospective parents with a personalized risk assessment of bearing a child with certain inherited conditions.
Histiocytic neoplasms - Insights
Learn more about how Mayo Clinic Laboratories’ next-generation sequencing panel for histiocytic neoplasms can help physicians accurately diagnose patients and guide treatment for their patients.